US counties with higher numbers of legal cannabis dispensaries recorded lower levels of opioid-related deaths relative to other locales, according to a new study.
The Portland-based lab received the green light from the Maine Office of Marijuana Policy on Friday, January 22.
As the study was purely observational, the researchers do not suggest any type of causality or mechanism behind these associations. But they do recommend further studies to help inform policy and treatment decisions.
Researchers from New York University found that relative usage rates of cannabis were up 13 percent at the end of each year compared to the first quarter.
The federal study aims to improve the testing standards used throughout the cannabis lab sector. Any lab interested in participating in the next phase of the project has until February 5 to enroll.
In a win for hemp farmers, the final rule widens the margin of error for THC levels in hemp plants before a cultivator is declared criminally negligent. However, several high-profile sticking points remain, including some guidelines on sampling.
Responding to Analytical Cannabis, ProVerde president Chris Hudalla explained that the Maine lab was “in operation before there were any requirements or mechanisms for licensing of marijuana testing laboratories in Maine.”